One year of qualification
Audited Supplier
In This Store
Category:Intermediates > Pharmaceutical Intermediates
Product Name:2-Nitrobenzyl alcohol，612-25-9
CAS No.:612-25-9
Standard:In-house Standards
Price(USD):Negotiable
Company:Nanjing Hike Biological Technology Co., Ltd
Grade: Chemical Grade
Factory Location: NANJING
Main Sales Markets: Middle East
Contract Manufacturing: CRO
Packaging Information: 25kg/bag
Delivery Lead Time: spot supply
Sample Provided: yes
Payment Terms: L/C
Basic information
|
alias |
Ortho nitrobenzyl alcohol; 2-Nitrobenzyl alcohol;
|
| CAS No. | 612-25-9 |
| EINECS | 210-302-6 |
| Molecular formula | C7H7NO3 |
| molecular weight | 153.14 |
| melting point | 69-72 °C(lit.) |
| solubility | Dissolved in methanol |
| boiling point | 270 °C(lit.) |
| density | 1.3386 (rough estimate) |
Product indicators
| appearance | Crystalline powder ranging from beige to beige |
| Content (GC) | ≥98.0% |
| Dry weight loss | ≤0.5% |
| Refractive index | 1.5030 (estimate) |
| Storage conditions | Store in the dark, inert gas, and at room temperature |
Security Information
| Dangerous goods signs | Xi,C,F |
| Hazard category code | 11-34 |
| Safety instructions | 22-24/25-45-36/37/39-26-16 |
| WGK Germanys | 3 |
| RTECS nuber | DP0657050 |
| Customs Number | 29062900 |
Supply capacity
We maintain spot inventory to ensure spot supply.
Packaging and Transportation
Conventional packaging: 25kg/bag with plastic inside and woven outside packaging
Alternatively, we can use ton bags at a rate of 500 kilograms per bag
Meanwhile, we also support other packaging options
We also support other packaging options. If you have any needs, please contact us.
FAQ
Q: Can you provide samples?
A: Yes, please contact sales to inquire about sample matters.
Q: Is there a minimum order quantity?
A: No, we support any quantity, from grams to tons.
purpose
Usage 1: Used as a pharmaceutical intermediate;
Usage 2: Used as a chemical reagent and for organic synthesis;
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight January 2025
